Functional versus chemical diversity: is biodiversity important for drug discovery?
- 1 May 2002
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (5) , 225-231
- https://doi.org/10.1016/s0165-6147(02)02007-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hazel Trees Offer New Source of Cancer DrugScience, 2000
- Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug developmentPublished by Elsevier ,1998
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- The Future of BiodiversityScience, 1995
- Bibenzyl cannabinoid and bisbibenzyl derivative from the liverwort Radula perrottetiiPhytochemistry, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- ISOLATION OF OPIATE RECEPTOR LIGANDS IN COFFEEClinical and Experimental Pharmacology and Physiology, 1987
- Detection of Pericine, a New CNS-active Indole Alkaloid fromPicralima nitidaCell Suspension Culture by Opiate Receptor Binding StudiesPlanta Medica, 1982
- Marijuana, absinthe and the central nervous systemNature, 1975
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964